Doximity Shares Outstanding 2020-2025 | DOCS
Doximity shares outstanding history from 2020 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Doximity shares outstanding for the quarter ending June 30, 2025 were 0.201B, a 0.97% increase year-over-year.
- Doximity 2025 shares outstanding were 0.201B, a 2.2% decline from 2024.
- Doximity 2024 shares outstanding were 0.206B, a 3.6% decline from 2023.
- Doximity 2023 shares outstanding were 0.213B, a 11.73% increase from 2022.
| Doximity Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025 | 201 |
| 2024 | 206 |
| 2023 | 213 |
| 2022 | 191 |
| 2021 | 95 |
| 2020 | 82 |
| 2019 | 76 |
| Doximity Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-06-30 | 201 |
| 2025-03-31 | 201 |
| 2024-12-31 | 202 |
| 2024-09-30 | 200 |
| 2024-06-30 | 199 |
| 2024-03-31 | 206 |
| 2023-12-31 | 200 |
| 2023-09-30 | 209 |
| 2023-06-30 | 212 |
| 2023-03-31 | 213 |
| 2022-12-31 | 212 |
| 2022-09-30 | 214 |
| 2022-06-30 | 215 |
| 2022-03-31 | 191 |
| 2021-12-31 | 216 |
| 2021-09-30 | 217 |
| 2021-06-30 | 115 |
| 2021-03-31 | 95 |
| 2020-12-31 | 100 |
| 2020-09-30 | 92 |
| 2020-06-30 | 85 |
| 2020-03-31 | |
| 2019-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $12.349B | $0.570B |
| Doximity Inc. provides digital platform for medical professionals. The company's network members include physicians across all specialties and practice areas. It provide its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and conduct virtual patient visits. Doximity Inc. is based in SAN FRANCISCO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.099B | 58.65 |
| Tempus AI (TEM) | United States | $13.629B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $10.193B | 83.52 |
| IRhythm Technologies (IRTC) | United States | $5.074B | 0.00 |
| Hinge Health (HNGE) | United States | $4.605B | 0.00 |
| Privia Health (PRVA) | United States | $2.623B | 194.27 |
| Inspire Medical Systems (INSP) | United States | $2.613B | 38.41 |
| Heartflow (HTFL) | $2.433B | 0.00 | |
| Phreesia (PHR) | United States | $1.732B | 0.00 |
| Enovis (ENOV) | United States | $1.689B | 8.93 |
| 10x Genomics (TXG) | United States | $1.676B | 0.00 |
| Schrodinger (SDGR) | United States | $1.476B | 0.00 |
| Omnicell (OMCL) | United States | $1.452B | 27.97 |
| Azenta (AZTA) | United States | $1.394B | 60.84 |
| Clover Health Investments (CLOV) | United States | $1.338B | 0.00 |
| Claritev (CTEV) | United States | $1.189B | 0.00 |
| Evolent Health (EVH) | United States | $1.059B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.659B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.630B | 0.00 |
| Veradigm (MDRX) | United States | $0.503B | 0.00 |
| Standard BioTools (LAB) | United States | $0.482B | 0.00 |
| Talkspace (TALK) | United States | $0.435B | 130.00 |
| Butterfly Network (BFLY) | United States | $0.363B | 0.00 |
| Carlsmed (CARL) | $0.349B | 0.00 | |
| TruBridge (TBRG) | United States | $0.290B | 50.90 |
| Outset Medical (OM) | United States | $0.243B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.236B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.224B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.211B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.195B | 0.00 |
| CapsoVision (CV) | United States | $0.187B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.141B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.125B | 0.00 |
| American Well (AMWL) | United States | $0.117B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 5.23 |
| EUDA Health Holdings (EUDA) | Singapore | $0.098B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.076B | 0.00 |
| Pulmonx (LUNG) | United States | $0.065B | 0.00 |
| 111 (YI) | China | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.050B | 0.00 |
| HeartBeam (BEAT) | United States | $0.041B | 0.00 |
| Precipio (PRPO) | United States | $0.024B | 0.00 |
| Zhongchao (ZCMD) | China | $0.023B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.019B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.009B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.005B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |